Cholesterol paves the way for topically applied viricides.
Sexually transmitted viral infections have the potential to be prevented and treated by topical viricides. Here, Wu et al. (2009) demonstrate that cholesterol-conjugated small interfering RNAs (siRNAs) targeting a cellular receptor combined with an antiviral siRNA when topically applied to mucosal tissue blocked lethal herpes virus infections in mice.